New technologies emerging from the Human Genome Project and the rapidly expanding direct-to-consumer DNA testing have provided a challenging environment for the entry of pharmacogenomics into clinical ...

Pharmacogenomics studies how individuals respond to drugs based on their genetic code. Using that knowledge to guide prescribing in routine care could lead to better outcomes for patients and save ...

As part of this initiative, PGxAI will roll out a suite of pharmacogenomic reports on Sequencing.com that provide personalized drug implications based on an individual’s genomic data. They directly ...

Quest Diagnostics is launching a new pharmacogenomics program designed to decode patients’ DNA to predict how they will respond to certain therapies and doses. The company said its test will span ...

KUALA LUMPUR: The human body is marvellously complex, and so is the science of treatment. Today, the field of medicine has become ever more targeted and specialised, with pharmacogenomics providing ...

Depression affects millions globally, presenting a significant challenge for effective treatment. Traditional approaches often rely on trial and error to find ...

Wasatch BioLabs (WBL), a Renew Biotechnologies subsidiary, and the largest U.S. sequencing service provider dedicated exclusively to long-read sequencing, today announced the addition of three Oxford ...